Cited by 434Cannabis and Cannabinoid ResearchRheumatoid Arthritis Research and TherapiesNatural Compounds in Disease Treatment

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis

Blake, D. R., Robson, P., Ho, M., Jubb, R. W., McCabe, C. S.·2006·Rheumatology

DOI 10.1093/rheumatology/kei183

Open this paper in CoChat — free account

Abstract

OBJECTIVES: To assess the efficacy of a cannabis-based medicine (CBM) in the treatment of pain due to rheumatoid arthritis (RA). METHODS: We compared a CBM (Sativex) with placebo in a randomized, double-blind, parallel group study in 58 patients over 5 weeks of treatment. The CBM was administered by oromucosal spray in the evening and assessments were made the following morning. Efficacy outcomes assessed were pain on movement, pain at rest, morning stiffness and sleep quality measured by a numerical rating scale, the Short-Form McGill Pain Questionnaire (SF-MPQ) and the DAS28 measure of disease activity. RESULTS: Seventy-five patients were screened and 58 met the eligibility criteria. Thirty-one were randomized to the CBM and 27 to placebo. Mean (S.D.) daily dose achieved in the final treatment week was 5.4 (0.84) actuations for the CBM and 5.3 (1.18) for placebo. In comparison with placebo, the CBM produced statistically significant improvements in pain on movement, pain at rest, quality of sleep, DAS28 and the SF-MPQ pain at present component. There was no effect on morning stiffness but baseline scores were low. The large majority of adverse effects were mild or moderate, and there were no adverse effect-related withdrawals or serious adverse effects in the active treatment group. CONCLUSIONS: In the first ever controlled trial of a CBM in RA, a significant analgesic effect was observed and disease activity was significantly suppressed following Sativex treatment. Whilst the differences are small and variable across the population, they represent benefits of clinical relevance and show the need for more detailed investigation in this indication.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/rheumatology/kei183

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The short-form McGill pain questionnaire
Melzack, R. (1987) · Pain · doi:10.1016/0304-3959(87)91074-8 · Cited by 4,368
Cannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients
Wade, D. T., Makela, P., Robson, P., House, H., & Bateman, C. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1082oa · Cited by 589
Self-citation
Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?
McPartland, J. M., & Russo, E. B. (2001) · Journal of Cannabis Therapeutics · doi:10.1300/j175v01n03_08 · Cited by 321
Effect of Δ-9-Tetrahydrocannabinol and Cannabidiol on Nocturnal Sleep and Early-Morning Behavior in Young Adults
Nicholson, A. N., Turner, C., Stone, B. M., & Robson, P. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000125688.05091.8f · Cited by 291
Self-citation
The medicinal use of cannabis in the UK: results of a nationwide survey
Ware, M. A., Adams, H., & Guy, G. W. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2004.00271.x · Cited by 239
Analgesic and antiinflammatory activity of constituents ofCannabis sativa L.
Formukong, E. A., EVANS, A. T., & Evans, F. J. (1988) · Inflammation · doi:10.1007/bf00915771 · Cited by 130
Human Studies of Cannabinoids and Medicinal Cannabis
Robson, P. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_25 · Cited by 78
Self-citation
The Medicinal Uses of Cannabis and Cannabinoids
Guy, G. W., Whittle, B. A., & Robson, P. (2008) · Le Pharmacien Hospitalier · doi:10.1016/s0768-9179(08)70455-3 · Cited by 47
Self-citation

Show all 10 references

Sorted by citations

Items 101–200 of 434

Cannabinoid Receptors: A brief history and "what's hot".
Graham, E. S. (2009) · Frontiers in bioscience · doi:10.2741/3288 · Cited by 71
Smoke Gets in Your Eyes: Medical Marijuana Laws and Tobacco Cigarette Use
Choi, A., Dave, D., & Sabia, J. J. (2018) · American Journal of Health Economics · doi:10.1162/ajhe_a_00121 · Cited by 68
Cannabis and pain: a scoping review
Pantoja‐Ruiz, C., Restrepo-Jiménez, P., Castañeda‐Cardona, C., Ferreirós, A., & Rosselli, D. (2021) · Brazilian Journal of Anesthesiology (English Edition) · doi:10.1016/j.bjane.2021.06.018 · Cited by 77
Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature
Wolfe, D. M., Corace, K., Butler, C., Rice, D. B., Skidmore, B., Patel, Y., Thayaparan, P., Michaud, A., Hamel, C., Smith, A., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281826 · Cited by 70
Advances in anti-inflammatory medicinal plants and phytochemicals in the management of arthritis: A comprehensive review
Gandhi, Y., Kumar, R. A., Grewal, J., Rawat, H., Mishra, S. K., Kumar, V. L., Shakya, S. K., Jain, V., Babu, G., Sharma, P., et al. (2022) · Food Chemistry Advances · doi:10.1016/j.focha.2022.100085 · Cited by 71
Effects of cannabinoid administration for pain: A meta-analysis and meta-regression.
Yanes, J. A., McKinnell, Z. E., Reid, M. A., Busler, J. N., Michel, J. S., Pangelinan, M. M., Sutherland, M. T., Younger, J., González, R., & Robinson, J. L. (2019) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000281 · Cited by 68
Evaluation and Treatment of Vulvodynia: State of the Science
Schlaeger, J. M., Glayzer, J. E., Villegas‐Downs, M., Li, H., Glayzer, E. J., He, Y., Takayama, M., Yajima, H., Takakura, N., Kobak, W. H., et al. (2022) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.13456 · Cited by 97
The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis
Rabgay, K., Waranuch, N., Chaiyakunapruk, N., Sawangjit, R., Ingkaninan, K., & Dilokthornsakul, P. (2019) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2019.07.015 · Cited by 69
Cannabinoids concentration variability in cannabis olive oil galenic preparations
Carcieri, C., Tomasello, C., Simiele, M., Nicolò, A. D., Avataneo, V., Canzoneri, L., Cusato, J., Perri, G. D., & D’Avolio, A. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12845 · Cited by 64
Cannabinoids for the treatment of rheumatic diseases — where do we stand?
Katz, D., Katz, I., Porat-Katz, B.-S., & Shoenfeld, Y. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0025-5 · Cited by 68
Expression of Cannabinoid Receptors in Human Osteoarthritic Cartilage: Implications for Future Therapies
Dunn, S. L., Wilkinson, J. M., Crawford, A., Bunning, R. A. D., & Le Maitre, C. L. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2015.0001 · Cited by 62
Cannabinergic Pain Medicine: A Concise Clinical Primer and Survey of Randomized-controlled Trial Results
Aggarwal, S. K. (2013) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31824c5e4c · Cited by 62
Role of Cannabinoids in Pain Management
Russo, E. B., & Hohmann, A. G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1560-2_18 · Cited by 62
Involvement of the endocannabinoid system in osteoarthritis pain
Porta, C. L., Bura, S. A., Negrete, R., & Maldonado, R. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12468 · Cited by 61
Traditional plant based medicines used to treat musculoskeletal disorders in Northern Pakistan
Malik, K., Ahmad, M., Zhang, G., Rashid, N., Zafar, M. N., Sultana, S., & Shah, S. N. (2018) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2018.02.003 · Cited by 62
The Effect of Medical Marijuana Laws on Labor Market Outcomes
Sabia, J. J., & Nguyen, T. T. (2018) · The Journal of Law and Economics · doi:10.1086/701193 · Cited by 61
The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain
Bebee, B., Taylor, D. M., Bourke, E. M., Pollack, K., Foster, L., Ching, M. S., & Wong, A. (2021) · The Medical Journal of Australia · doi:10.5694/mja2.51014 · Cited by 63
Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids
O’Brien, M. S., & McDougall, J. J. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.03.012 · Cited by 60
Traditional uses of Cannabis: An analysis of the CANNUSE database
Balant, M., Gras, A., Ruz, M., Vallès, J., Vitales, D., & Garnatje, T. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114362 · Cited by 58
A Multiple‐Dose, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray
Sellers, E. M., Schoedel, K. A., Bartlett, C., Romach, M. K., Russo, E. B., Stott, C. G., Wright, S., White, L., Duncombe, P., & Chen, C. (2013) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.36 · Cited by 57
Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada
Cahill, S. P., Lunn, S. E., Diaz, P. L., & Page, J. E. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.626853 · Cited by 56
Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs
Parmar, J. R., Forrest, B. D., & Freeman, R. A. (2015) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2015.09.002 · Cited by 57
The use of cannabinoids in animals and therapeutic implications for veterinary medicine: a review
Landa, L., Šulcová, A., & Gbelec, P. (2016) · Veterinární Medicína · doi:10.17221/8762-vetmed · Cited by 61
A Metabolomic Approach Applied to a Liquid Chromatography Coupled to High‐Resolution Tandem Mass Spectrometry Method (HPLC‐ESI‐HRMS/MS): Towards the Comprehensive Evaluation of the Chemical Composition of Cannabis Medicinal Extracts
Citti, C., Battisti, U. M., Braghiroli, D., Ciccarella, G., Schmid, M. G., Vandelli, M. A., & Cannazza, G. (2017) · Phytochemical Analysis · doi:10.1002/pca.2722 · Cited by 58
Therapeutic Uses of Cannabis on Sleep Disorders and Related Conditions
Choi, S., Huang, B. C., & Gamaldo, C. E. (2019) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0000000000000617 · Cited by 56
Herbal Medicine in the Treatment of Rheumatic Diseases
Ernst, E. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2010.11.004 · Cited by 56
Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature
Inglet, S., Winter, B., Yost, S. E., Entringer, S., Lian, A., Biksacky, M., Pitt, R. D., & Mortensen, W. (2020) · Annals of Pharmacotherapy · doi:10.1177/1060028020930189 · Cited by 56
??9-Tetrahydrocannabinol, 11-Hydroxy-??9-Tetrahydrocannabinol and 11-Nor-9-Carboxy-??9-Tetrahydrocannabinol in Human Plasma After Controlled Oral Administration of Cannabinoids
Goodwin, R. S., Gustafson, R. A., Barnes, A. J., Nebro, W., Moolchan, E. T., & Huestis, M. A. (2006) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200608000-00010 · Cited by 56
Joints for joints: cannabinoids in the treatment of rheumatoid arthritis
Lowin, T., Schneider, M., & Pongratz, G. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000590 · Cited by 55
Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials
Jeddi, H. M., Busse, J. W., Sadeghirad, B., Levine, M., Zoratti, M. J., Wang, L., Noori, A., Couban, R., & Tarride, J. (2024) · BMJ Open · doi:10.1136/bmjopen-2022-068182 · Cited by 62
Single dose delta‐9‐tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability
de Vries, M., Van Rijckevorsel, D. C. M., Vissers, K. C. P., Wilder‐Smith, O. H. G., & Van Goor, H. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12811 · Cited by 54
Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials
Dykukha, I., Malessa, R., Essner, U., & Ueberall, M. A. (2021) · Pain Medicine · doi:10.1093/pm/pnab050 · Cited by 55
Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice
Neelakantan, H., Tallarida, R. J., Reichenbach, Z. W., Tuma, R. F., Ward, S. J., & Walker, E. A. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000119 · Cited by 53
The Pharmacological History of Cannabis
Russo, E. B. (2014) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199662685.003.0002 · Cited by 53
Analgesic Effects of Cannabinoids for Chronic Non-cancer Pain: a Systematic Review and Meta-Analysis with Meta-Regression
Wong, S. S. C., Chan, W. S., & Cheung, C. W. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09905-y · Cited by 55
Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis
Velayudhan, L., McGoohan, K., & Bhattacharyya, S. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003524 · Cited by 56
A Randomized Controlled Trial of Topical Cannabidiol for the Treatment of Thumb Basal Joint Arthritis
Heineman, J. T., Forster, G. L., Stephens, K. L., Cottler, P. S., Timko, M. P., & DeGeorge, B. R. (2022) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2022.03.002 · Cited by 52
Therapeutic Potential of Plant-Derived Compounds and Plant Extracts in Rheumatoid Arthritis—Comprehensive Review
Kciuk, M., Garg, A., Rohilla, M., Chaudhary, R., Dhankhar, S., Dhiman, S., Bansal, S., Saini, M., Singh, T. G., Chauhan, S., et al. (2024) · Antioxidants · doi:10.3390/antiox13070775 · Cited by 61
Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain
Campbell, G., Stockings, E., & Nielsen, S. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0960-9 · Cited by 55
Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments
Stornaiuolo, M., Bruno, A., Botta, L., Regina, G. L., Cosconati, S., Silvestri, R., Marinelli, L., & Novellino, E. (2015) · Scientific Reports · doi:10.1038/srep15453 · Cited by 53
Research progress of cardioprotective agents for prevention of anthracycline cardiotoxicity.
Zhang, J., Cui, X., Yan, Y., Li, M., Yang, Y. J., Wang, J., & Zhang, J. (2016) · Europe PMC (PubMed Central) · Cited by 50
Evaluation of Sex Differences in Preclinical Pharmacology Research: How Far Is Left to Go?
Allegra, S., Chiara, F., Grazia, D. D., Gaspari, M., & Francia, S. D. (2023) · Pharmaceuticals · doi:10.3390/ph16060786 · Cited by 54
Therapeutic Potential of Cannabinoid-Based Drugs
Klein, T., & Newton, C. A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72005-0_43 · Cited by 49
Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes
Dunn, S. L., Wilkinson, J. M., Crawford, A., Le Maitre, C. L., & Bunning, R. A. D. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2013.10.016 · Cited by 46
Patient Perceptions of the Use of Medical Marijuana in the Treatment of Pain After Musculoskeletal Trauma: A Survey of Patients at 2 Trauma Centers in Massachusetts
Heng, M. M., McTague, M. F., Lucas, R. C., Harris, M. B., Vrahas, M. S., & Weaver, M. J. (2017) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000001002 · Cited by 46
Challenges to develop novel anti‐inflammatory and analgesic drugs
Botz, B., Bölcskei, K., & Helyes, Z. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1427 · Cited by 44
Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats
Fouad, A. A., Al-Mulhim, A. S., & Jresat, I. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.07.030 · Cited by 45
Effects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in rats
Niu, K. Y., Zhang, Y., & Ro, J. Y. (2012) · Pain · doi:10.1016/j.pain.2012.07.037 · Cited by 45
Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis
Barakji, J. A., Korang, S. K., Feinberg, J. B., Maagaard, M., Mathiesen, O., Gluud, C. N., & Jakobsen, J. C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0267420 · Cited by 48
Is There Any Clinically Relevant Cannabinoid-Induced Analgesia?
Kraft, B. (2012) · Pharmacology · doi:10.1159/000337376 · Cited by 45
Cannabinoids: The Lows and the Highs of Chemotherapy-Induced Nausea and Vomiting
Mortimer, T. L., Mabin, T., & Engelbrecht, A. (2019) · Future Oncology · doi:10.2217/fon-2018-0530 · Cited by 43
Protective Effects of Cannabidiol on Lesion-Induced Intervertebral Disc Degeneration
Silveira, J. W. S., Issy, A. C., Castania, V., Salmón, C. E. G., Nogueira‐Barbosa, M. H., Guimarães, F. S., Defino, H. L. A., & Bel, E. A. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113161 · Cited by 42
Identification of the Synthetic Cannabinoid R(+)WIN55,212-2 as a Novel Regulator of IFN Regulatory Factor 3 Activation and IFN-β Expression
Downer, E. J., Clifford, E., Gran, B., Nel, H. J., Fallon, P. G., & Moynagh, P. N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188599 · Cited by 41
Dronabinol and chronic pain: importance of mechanistic considerations
de Vries, M., van Rijckevorsel, D. C., Wilder‐Smith, O. H. G., & van Goor, H. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.918102 · Cited by 40
Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review
Bryk, M., & Starowicz, K. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00270-y · Cited by 40
Health Effects of Using Cannabis for Therapeutic Purposes: A Gender Analysis of Users’ Perspectives
Bottorff, J. L., Bissell, L. J. L., Balneaves, L. G., Oliffe, J. L., Kang, H. B. K., Capler, N. R., Buxton, J. A., & O’Brien, R. K. (2010) · Substance Use & Misuse · doi:10.3109/10826084.2010.537732 · Cited by 39
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats
Fouad, A. A., & Jresat, I. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.08.048 · Cited by 38
Decarbonylation: A metabolic pathway of cannabidiol in humans
Krämer, M., Broecker, S., Madea, B., & Heß, C. (2019) · Drug Testing and Analysis · doi:10.1002/dta.2572 · Cited by 38
Cannabis for pain in orthopedics: a systematic review focusing on study methodology
Madden, K., George, A., van der Hoek, N., Borim, F. M., Mammen, G., & Bhandari, M. (2019) · Canadian Journal of Surgery · doi:10.1503/cjs.001018 · Cited by 38
Personal experience and attitudes of pain medicine specialists in Israel regarding the medical use of cannabis for chronic pain
Sharon, H., Goldway, N., Goor‐Aryeh, I., Eisenberg, E., & Brill, S. (2018) · Journal of Pain Research · doi:10.2147/jpr.s159852 · Cited by 37
Cannabis for Pain and Headaches: Primer
Kim, P. S., & Fishman, M. A. (2017) · Current Pain and Headache Reports · doi:10.1007/s11916-017-0619-7 · Cited by 36
Cannabis and orofacial pain: a systematic review
Grossman, S., Tan, H., & Gadiwalla, Y. (2021) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2021.06.005 · Cited by 39
The Therapeutic Potential of Cannabis in Counteracting Oxidative Stress and Inflammation
Graczyk, M., Lewandowska, A. A., & Dzierżanowski, T. (2021) · Molecules · doi:10.3390/molecules26154551 · Cited by 36
Reassessment of the role of cannabinoids in the management of pain
Beaulieu, P., & Ware, M. (2007) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e3282efd175 · Cited by 34
Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies
Veiga, M., Azevedo‐Silva, J., & Fernandes, J. C. (2023) · Pharmaceuticals · doi:10.3390/ph16020155 · Cited by 36
Use of Cannabidiol in the Management of Insomnia: A Systematic Review
Ranum, R. M., Whipple, M. O., Croghan, I. T., Bauer, B., Toussaint, L. L., & Vincent, A. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0122 · Cited by 35
Cannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand?
Gonçalves, E. D., & Dutra, R. C. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.05.023 · Cited by 36
Medical cannabis and cannabinoids in rheumatology: where are we now?
Sarzi‐Puttini, P., Batticciotto, A., Atzeni, F., Bazzichi, L. M., Franco, M. D., Salaffi, F., Marotto, D., Ceribelli, A., Ablin, J. N., & Häuser, W. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1665997 · Cited by 34
Cannabidiol promotes adipogenesis of human and mouse mesenchymal stem cells via PPARγ by inducing lipogenesis but not lipolysis
Chang, R. C.-A., Thangavelu, C. S., Joloya, E. M., Kuo, Y., Li, Z., & Blumberg, B. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114910 · Cited by 34
Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice
Hoot, M. R., Sim‐Selley, L. J., Poklis, J. L., Abdullah, R. A., Scoggins, K. L., Selley, D. E., & Dewey, W. L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.105 · Cited by 34
Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases
Gonen, T., & Amital, H. (2020) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10389 · Cited by 34
Cannabis; adverse effects from an oromucosal spray
Scully, C. (2007) · BDJ · doi:10.1038/bdj.2007.749 · Cited by 30
Use of complementary therapies for chronic pain management in patients with reported Ehlers‐Danlos syndrome or hypermobility spectrum disorders
Demes, J. S., McNair, B., & Taylor, M. R. G. (2020) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61837 · Cited by 30
Piezoelectric peptide-hpDNA based electronic nose for the detection of terpenes; Evaluation of the aroma profile in different Cannabis sativa L. (hemp) samples
Gaggiotti, S., Palmieri, S., Pelle, F. D., Sergi, M., Cichelli, A., Mascini, M., & Compagnone, D. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.127697 · Cited by 29
Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: A placebo controlled randomized clinical trial
Hermush, V., Ore, L., Stern, N., Mizrahi, N., Fried, M., Krivoshey, M., Staghon, E., Lederman, V. E., & Schleider, L. B. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.951889 · Cited by 33
Cannabinoids in the treatment of rheumatic diseases: Pros and cons
Sarzi‐Puttini, P., Ablin, J. N., Trabelsi, A., Fitzcharles, M., Marotto, D., & Häuser, W. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102409 · Cited by 31
Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions
Furrer, D., Kröger, E., Marcotte, M., Jauvin, N., Bélanger, R. E., Ware, M. A., Foldes‐Busque, G., Aubin, M., Pluye, P., & Dionne, C. E. (2021) · Journal of Cannabis Research · doi:10.1186/s42238-021-00096-8 · Cited by 30
The Dilemma of Medical Marijuana Use by Rheumatology Patients
Fitzcharles, M., Clauw, D. J., Ste‐Marie, P. A., & Shir, Y. (2014) · Arthritis Care & Research · doi:10.1002/acr.22267 · Cited by 27
Assessment of Norwegian physicians’ knowledge, experience and attitudes towards medical cannabis
Arnfinsen, J. L., & Kısa, A. (2020) · Drugs Education Prevention and Policy · doi:10.1080/09687637.2020.1806208 · Cited by 27
Cannabis and Autoimmunity: Possible Mechanisms of Action
Giorgi, V., Marotto, D., Batticciotto, A., Atzeni, F., Bongiovanni, S. F., & Sarzi‐Puttini, P. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s267905 · Cited by 31
Is There a Place for Medicinal Cannabis in Treating Patients with Sleep Disorders? What We Know so Far
Maddison, K. J., Kosky, C. A., & Walsh, J. H. (2022) · Nature and Science of Sleep · doi:10.2147/nss.s340949 · Cited by 27
Beyond radio-displacement techniques for Identification of CB1 Ligands: The First Application of a Fluorescence-quenching Assay
Bruno, A., Lembo, F., Novellino, E., Stornaiuolo, M., & Marinelli, L. (2014) · Scientific Reports · doi:10.1038/srep03757 · Cited by 28
Medical marijuana and pain management
Temple, L. M. (2016) · Disease-a-Month · doi:10.1016/j.disamonth.2016.05.014 · Cited by 25
Managing neuropathic pain with Sativex®: a review of its pros and cons
Pérez, J., & Ribera, M. V. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.7.1189 · Cited by 26
Cannabinoids in the Management of Musculoskeletal Pain
Madden, K., van der Hoek, N., Chona, S., George, A., Dalchand, T., Baldawi, H., Mammen, G., & Bhandari, M. (2018) · JBJS Reviews · doi:10.2106/jbjs.rvw.17.00153 · Cited by 25
Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)
Boehnke, K. F., Häuser, W., & Fitzcharles, M. (2022) · Current Rheumatology Reports · doi:10.1007/s11926-022-01077-3 · Cited by 53
Using Cannabis to Treat Cancer-Related Pain
Byars, T., Theisen, E., & Bolton, D. L. (2019) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2019.04.012 · Cited by 25
Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective
Karst, M., & Wippermann, S. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802691951 · Cited by 24
Protective effect of cannabidiol against cadmium hepatotoxicity in rats
Fouad, A. A., Al-Mulhim, A. S., & Gomaa, W. M. (2013) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2013.07.001 · Cited by 23
RETRACTED: The endocannabinoid signaling pathway as an emerging target in pharmacotherapy, earmarking mitigation of destructive events in rheumatoid arthritis
Kaur, I., Behl, T., BUNGAU, S. G., Zengin, G., Kumar, A., El-Esawi, M. A., Khullar, G., Venkatachalam, T., & Arora, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118109 · Cited by 24
Retracted
Pharmacological pain management in patients with rheumatoid arthritis: a narrative literature review
Cox, N., Mallen, C. D., & Scott, I. C. (2025) · BMC Medicine · doi:10.1186/s12916-025-03870-0 · Cited by 22
Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases
Fitzcharles, M., & Häuser, W. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0625-5 · Cited by 24
Safety and Tolerability of Natural and Synthetic Cannabinoids in Older Adults: A Systematic Review and Meta-Analysis of Open-Label Trials and Observational Studies
Pisani, S., McGoohan, K., Velayudhan, L., & Bhattacharyya, S. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00882-2 · Cited by 22
The Efficacy of Cannabis in Reducing Back Pain: A Systematic Review
Price, R. L., Charlot, K. V., Frieler, S., Dettori, J. R., Oskouian, R. J., & Chapman, J. R. (2022) · Global Spine Journal · doi:10.1177/21925682211065411 · Cited by 21
Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain
Britch, S. C., & Craft, R. M. (2022) · Journal of Pain · doi:10.1016/j.jpain.2022.09.002 · Cited by 23
Chronic pain and cannabinoids. Great expectations or a christmas carol
Pascual, D., Sánchez-Robles, E., García, M. M., & Goicoechea, C. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.033 · Cited by 22
Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies
Cooper, Z. D., & Abrams, D. I. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1669628 · Cited by 21
Cannabinoids in the Treatment of Back Pain
Kim, T. E., Townsend, R. K., Branch, C. L., Romero-Sandoval, E. A., & Hsu, W. (2020) · Neurosurgery · doi:10.1093/neuros/nyz573 · Cited by 21
Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years” accumulated evidence from clinical trials
González, J. M. P., & Silván, C. V. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1935879 · Cited by 23
Medical cannabis for orthopaedic patients with chronic musculoskeletal pain: does evidence support its use?
Johal, H. S., Vannabouathong, C., Chang, Y., Zhu, M. T., & Bhandari, M. (2020) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x20937968 · Cited by 20

Authors: Blake, D. R., Robson, P., Ho, M., Jubb, R. W., & McCabe, C. S.
Affiliations: Royal National Hospital for Rheumatic Diseases (GB)
University of Oxford (GB)
Northampton General Hospital (GB)
Selly Oak Hospital (GB)
Corresponding author: Blake, D. R.
ORCID: McCabe, C. S.
Venue: Rheumatology
Publisher: Oxford University Press (OUP)
Published: 2005-11-09
Volume: 45
Issue: 1
Pages: 50-52
ISSN: 1462-0324 (ISSN-L)
1462-0332
DOI: 10.1093/rheumatology/kei183
OpenAlex: W2155565260
Cited by: 433
References: 10
Citations by year: 2026: 16 · 2025: 24 · 2024: 25 · 2023: 19 · 2022: 45 · 2021: 34 · 2020: 37 · 2019: 35 · 2018: 31 · 2017: 19 · 2016: 22 · 2015: 14 · 2014: 18 · 2013: 11 · 2012: 16
FWCI: 6.37
Type: journal article
Language: en
Open access: closed
Locations: Lara D. Veeken (publishedVersion)
PubMed (publishedVersion)
Funders: GW Pharmaceuticals
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
Keywords: Sativex, cannabis-based medicines, rheumatoid arthritis, pain, oromucosal spray, analgesia, disease activity, sleep quality, morning stiffness, tolerability, adverse effects
MeSH terms: Administration, Oral, Analgesics, Arthritis, Rheumatoid, Cannabidiol, Double-Blind Method, Drug Combinations, Female, Humans, Male, Middle Aged, Pain, Pain Measurement, Plant Extracts, Dronabinol, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks